SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 90 of 100
Features
Stocks, economic growth, and a Fed conference — 5 things to know this week
By
Tom Huddleston Jr.
August 23, 2015
Health
Valeant snaps up ‘Female Viagra’ maker Sprout for $1 billion
By
Geoffrey Smith
August 20, 2015
Features
This is the fastest growing company in the U.S.
By
Laura Lorenzetti
August 19, 2015
Health
Female Viagra and a Fed update–5 things to know today
By
Laura Lorenzetti
and
Geoffrey Smith
August 19, 2015
Health
This is what it’s like to take ‘Female Viagra’
By
TIME
August 19, 2015
Health
‘Female Viagra’ drug approved by FDA
By
TIME
August 19, 2015
Health
‘Female Viagra’ could get approval today
By
Michal Addady
August 18, 2015
Finance
Why drug companies are betting big on ‘pharmerging’ countries
By
Laura Lorenzetti
August 14, 2015
Health
CVS/Caremark will no longer cover these drugs, including Viagra
By
Chris Matthews
August 7, 2015
Features
Ackman’s back and Allergan — 5 things to know today
By
Tom Huddleston Jr.
and
Geoffrey Smith
August 6, 2015
Health
Shire offers to buy rival drugmaker Baxalta for $30 billion
By
Reuters
August 4, 2015
Finance
From Actavis to Allergan: One pharma company’s wild dealmaking journey
By
Stacy Jones
,
Kacy Burdette
and
Jen Wieczner
July 30, 2015
Tech
IBM Watson Health now counts CVS Health as a partner
By
Jonathan Vanian
July 30, 2015
Tech
Medical marijuana firm Potbotics to launch ‘virtual budtenders’
By
Dan Reilly
July 28, 2015
Finance
The real reasons for the pharma merger boom
By
Jen Wieczner
July 28, 2015
Most Popular
AI
Meta's 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is 'vibe coding' right now
By
Eva Roytburg
Economy
Ray Dalio says the world is running out of interest in buying U.S. debt—but America is unable to cut back its spending
By
Eleanor Pringle
Politics
First Tucker Carlson, now Ted Cruz: Conservatives are talking about an ‘unbelievably dangerous’ precedent being set by...
By
Nino Paoli